Note 14 - Capital and Other Components of Equity (Details Textual) $ / shares in Units, $ / shares in Units, $ in Millions |
|
|
|
|
|
|
1 Months Ended |
2 Months Ended |
12 Months Ended |
13 Months Ended |
|
|
|
Feb. 14, 2019
USD ($)
|
Oct. 23, 2018
CAD ($)
$ / shares
shares
|
May 14, 2018
CAD ($)
$ / shares
shares
|
May 09, 2018
CAD ($)
$ / shares
shares
|
Dec. 27, 2017
CAD ($)
$ / shares
shares
|
Dec. 27, 2017
USD ($)
$ / shares
shares
|
Feb. 21, 2017
CAD ($)
$ / shares
shares
|
Oct. 31, 2018
CAD ($)
shares
|
Oct. 31, 2018
USD ($)
$ / shares
shares
|
May 31, 2018
CAD ($)
$ / shares
shares
|
Mar. 31, 2017
CAD ($)
|
Mar. 31, 2019
CAD ($)
$ / shares
shares
|
Mar. 31, 2019
CAD ($)
$ / shares
shares
|
Mar. 31, 2019
CAD ($)
$ / shares
$ / shares
shares
|
Mar. 31, 2018
CAD ($)
|
Mar. 31, 2018
CAD ($)
$ / shares
|
Dec. 31, 2017
CAD ($)
$ / shares
shares
|
Feb. 28, 2017
CAD ($)
|
Feb. 28, 2017
CAD ($)
$ / shares
|
Mar. 31, 2017
CAD ($)
|
Mar. 31, 2019
$ / shares
|
Feb. 14, 2019
CAD ($)
|
Dec. 27, 2017
$ / shares
shares
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At-the-market sales agreement, estimated aggregate gross proceeds |
|
$ 30.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At-the-market sales agreement, term |
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At-the-market sales agreement, fee, percentage |
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuing shares |
|
|
$ 25,400,000
|
|
|
|
|
|
$ 22,600,000
|
$ 17.4
|
|
$ (34,000)
|
$ 0
|
$ 57,892,000
|
|
$ 11,065,000
|
|
|
$ 5,044,000
|
|
$ 5,010,000
|
|
|
|
Deferred financing costs, current |
|
|
|
|
|
|
|
|
|
|
|
|
179,000
|
179,000
|
$ 179,000
|
|
|
|
|
|
|
|
$ 179,000
|
|
Number of shares issued in public offering | shares |
|
|
18,750,000
|
|
|
|
|
|
16,600,000
|
16,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share issued, price per share | (per share) |
|
|
$ 1.28
|
|
|
|
|
$ 1.57
|
|
$ 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuing shares in public offering, gross |
|
|
$ 27,600,000
|
|
|
|
|
|
$ 24,700,000
|
$ 19.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of equity, number of shares | shares |
|
|
21,562,500
|
|
9,530,000
|
|
|
|
19,090,000
|
19,090,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of units issued during period | shares |
|
|
|
|
9,530,000
|
9,900,990
|
9,900,990
|
3,930,518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unit issued, price per unit | (per share) |
|
|
|
|
$ 1.05
|
|
|
$ 1.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.01
|
Proceeds from issuing units |
|
|
|
|
$ 10,000,000
|
$ 12,600,000
|
$ 10.0
|
$ 5,699,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued during period | shares |
|
|
|
|
9,530,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | (per share) |
|
|
|
|
$ 1.31
|
|
$ 1.2625
|
$ 2.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
54,407,000
|
|
6,575,000
|
|
|
4,653,000
|
|
|
|
|
|
Unit issuance costs |
|
|
|
|
|
|
|
$ 1,190,000
|
|
|
|
|
|
$ 1,800,000
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by warrants | shares |
|
|
|
|
|
495,050
|
|
234,992
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
495,050
|
Warrant costs |
|
|
|
|
|
$ 406,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unit, shares of class A share | shares |
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unit, shares of class A share purchase warrant | shares |
|
|
|
|
|
|
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by each warrant | shares |
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
|
|
|
|
|
|
|
$ 144,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average share price |
|
|
|
|
|
|
|
$ 2.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) from equity settled non-employee share-based payment, shares | shares |
|
|
|
|
|
|
|
60,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) from equity settled non-employee share-based payment |
|
|
|
|
|
|
|
$ 94,000
|
|
|
|
|
|
|
|
|
|
|
94,000
|
|
|
|
|
|
Share-based payment costs allocated to share capital |
|
|
|
|
|
|
|
85,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payment costs allocated to debt |
|
|
|
|
|
|
|
$ 9,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercised, equity shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
772,474
|
|
|
|
|
|
|
|
|
|
|
Number of warrants exercised | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
775,855
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,011,000
|
|
384,000
|
|
|
|
|
|
|
|
|
May 2018 public offering warrants 2018 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 1.31
|
|
|
$ 1.31
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
[1] |
|
|
|
|
|
|
|
|
|
|
|
8,246,000
|
$ 8,246,000
|
$ 8,246,000
|
|
|
|
|
|
|
|
|
|
Number of warrants exercised | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
771,400
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
Series December 2017 US public offering warrants 2017 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.26
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
[2] |
|
|
|
|
|
|
|
|
|
|
|
8,017,000
|
8,017,000
|
$ 8,017,000
|
6,405,000
|
6,405,000
|
|
|
|
|
|
|
|
Series 8 December 2013 Public offering warrants related to liability [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
[3] |
|
|
|
|
|
|
|
|
|
|
209,000
|
|
|
|
21,000
|
21,000
|
|
187,000
|
187,000
|
209,000
|
|
|
|
Exercise price for 10 warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15
|
|
|
Warrants exercised, equity shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,074
|
|
|
|
|
|
|
|
|
|
|
Number of warrants exercised | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
4,455
|
|
|
|
|
|
|
|
|
|
|
Public offering broker warrants May 2018 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.05
|
|
|
|
|
|
|
|
|
|
|
Public offering warrants February 2017, equity portion [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | (per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.2625
|
|
|
$ 2.15
|
|
|
|
|
|
|
Warrants and rights outstanding |
[4] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants exercised | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178,721
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 384,000
|
|
|
|
|
|
|
Series December 2017 US Broker warrants, equity portion [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.15
|
|
|
|
|
|
|
|
|
|
|
The 2017 Unsecured convertible debenture conversion option and contingent warrant related to equity [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.90
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
[5] |
|
|
|
|
|
|
|
|
|
|
309,000
|
309,000
|
$ 309,000
|
309,000
|
309,000
|
309,000
|
|
309,000
|
309,000
|
309,000
|
|
|
|
Deferred tax expense (income) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 129,000
|
|
|
|
|
|
|
|
|
|
|
Series 9 Private Placement warrants 2013 related to equity [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.30
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
[6] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 2017-BW Broker warrants related to equity [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.15
|
|
|
|
|
|
|
|
|
|
|
Warrants exercised, equity shares issued, amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 71,000
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding |
[7] |
|
|
|
|
|
|
|
|
|
|
$ 144,000
|
|
|
|
|
|
|
144,000
|
$ 144,000
|
$ 144,000
|
|
|
|
Warrants exercised, equity shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
117,496
|
|
|
|
|
|
|
|
|
|
|
Warrants expired | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
117,496
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 283,000
|
|
406,000
|
|
|
144,000
|
|
|
|
|
|
Warrant costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
144
|
|
|
|
|
|
|
|
|
Increase (decrease) from equity settled non-employee share-based payment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriter [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by warrants | shares |
|
|
|
|
|
892,044
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
892,044
|
Warrants exercised, equity shares issued, amount |
|
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
6,200,000
|
|
|
|
|
|
|
|
|
|
|
Unit issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
|
|
|
Class A shares [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of units issued during period | shares |
|
|
|
|
|
9,900,990
|
9,900,990
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities issued May 2018 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | (per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.31
|
|
|
|
|
|
|
|
|
|
|
Fair value per shares issuable warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
0.39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative warrant liabilities [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financial liabilities at fair value through profit or loss |
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,300,000
|
$ 4,300,000
|
$ 4,300,000
|
5,900,000
|
$ 5,900,000
|
|
|
|
|
|
|
|
Unit issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 700,000
|
|
|
|
|
|
|
|
|
|
|
Warrant costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,500,000
|
|
|
|
|
|
|
|
|
Warrant liabilities issued December 27, 2017 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of units issued during period | shares |
|
|
|
|
|
8,910,891
|
8,910,891
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.26
|
|
|
|
|
$ 1.26
|
|
|
|
|
Fair value per shares issuable warrants | $ / shares |
|
|
|
|
|
$ 0.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriter [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued for option exercised | shares |
|
|
2,812,500
|
|
|
|
|
|
2,490,000
|
2,490,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of equity, number of shares | shares |
|
|
|
1,429,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of units issued during period | shares |
|
|
|
1,429,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unit issued, price per unit | $ / shares |
|
|
|
$ 1.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuing units |
|
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants issued during period | shares |
|
|
|
1,429,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
$ 1.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriter [member] | Warrant liabilities issued May 2018 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
$ 1.31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Broker [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price, warrants issued | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 1.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares called by warrants | shares |
|
|
|
|
|
|
|
|
|
|
547,975
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant costs |
|
|
|
|
|
|
|
|
|
|
$ 283,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cumulative dividend rate |
|
|
|
|
|
|
|
|
|
|
|
|
5.00%
|
5.00%
|
5.00%
|
|
|
|
|
|
|
|
|
|
Conversion ratio |
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
Redeemable price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.80
|
$ 0.80
|
$ 0.80
|
|
|
|
|
|
|
|
|
|
Total number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
|
|
|
|
|
Number of shares outstanding at end of period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
|
|
|
|
|
Class C shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cumulative dividend rate |
|
|
|
|
|
|
|
|
|
|
|
|
5.00%
|
5.00%
|
5.00%
|
|
|
|
|
|
|
|
|
|
Conversion ratio |
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
Redeemable price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.20
|
$ 0.20
|
$ 0.20
|
|
|
|
|
|
|
|
|
|
Total number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
|
|
|
|
|
Number of shares outstanding at end of period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
|
|
|
|
|
Class D and E shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion ratio |
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
Total number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
|
|
|
|
|
Class D and E shares [Member] | Bottom of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cumulative dividend rate |
|
|
|
|
|
|
|
|
|
|
|
|
0.50%
|
0.50%
|
0.50%
|
|
|
|
|
|
|
|
|
|
Class D and E shares [Member] | Top of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cumulative dividend rate |
|
|
|
|
|
|
|
|
|
|
|
|
2.00%
|
2.00%
|
2.00%
|
|
|
|
|
|
|
|
|
|
Class A shares [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
|
|
|
|
|
Number of shares outstanding at end of period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
0
|
|
|
|
|
|
|
|
|
|
|
|